Author Archives : Mohan Garikiparithi

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.

Advertisement

Possible obesity gene discovered

In what could be a significant breakthrough in the ‘battle of the bulge’, a potential obesity causing gene has been discovered by researchers at the University of British Columbia. The gene is found in every human, and encodes a protein called 14-3-3zeta, which is responsible for adipogenesis (production of fat cells) and the growth of ...click here to read more

Patients not getting recommended blood clot treatment: Study

The risk of deadly venous thromboembolism (VTE) remains a huge concern for health authorities as many health care providers aren’t following recommended procedures said researchers. VTE, which is the most common cause of preventable death in healthcare settings, can either be in the form of coagulated (clotted) blood in peripheral veins, or pulmonary embolism (PE), ...click here to read more

Price tag on prescriptions called gimmick

Drug and Therapeutics Bulletin (dtb) slams the idea of adding a price tag to prescription medicines that cost more than $30 (£20). The popular pharma bulletin sees this as just another “headline grabbing gimmick,” and warns that it could mislead patients into believing that cheaper drugs are less effective and therefore less important. The initiative to ...click here to read more

Advertisement

Topical gel treats T cell lymphoma

In what is being seen as a huge leap in cancer research, researchers at the Perelman School of Medicine at the University of Pennsylvania, have shown a topical gel might eliminate early stage malignant T cells and help reduce the lesions. Results of a phase-one trial show that the topical resiquimod gel, helps against both ...click here to read more

Control inflammation to reduce chronic disease: Experts

It all comes down to what you eat. In a recent article published in the British Journal of Nutrition, a coalition of experts explain how nutrition influences inflammatory processes. Inflammation is both good and bad. Acute inflammation is a friend and plays an important role in essential metabolic regulation and in host defense. But if inflammation remains ...click here to read more

Google Glass brings specialists to remote patients

In the present age of value-based care, a toxicology service using hands-free devices, such as Google Glass, could potentially expand its coverage area and enhance patient care, without putting a dent on the patient’s pocket. Researchers at the University of Massachusetts Medical School have found that the head-mounted streaming audio/video device Google Glass could be ...click here to read more

Advertisement